AstraZeneca

AstraZeneca 3rd dose increases antibody response against Omicron

Oxford-AstraZeneca begins work on vaccine to target Omicron

Oxford-AstraZeneca Covid vax protection wanes after 3 months: Lancet

AstraZeneca's antibody shot 83% effective at preventing Covid

AstraZeneca's antibody cocktail can prevent, treat Covid-19

India calls UK’s stand on Covishiled ‘discriminatory’, warns of reciprocal action

EU, AstraZeneca reach agreement on Covid vaccine supply dispute

AstraZeneca Covid vaccine protection may last a lifetime: Study

AstraZeneca tests Covid booster shots against Beta-variant

AstraZeneca says 92% vaccine effectiveness against Delta variant